Compounds > 8-hydroxy-2-(di-n-propylamino)tetralin
Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Weight Loss

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Weight Loss in 2 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Weight Loss: Decrease in existing BODY WEIGHT.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Garrett, TL1
Joshi, K1
Rapp, CM1
Chapleau, M1
Cool, DR1
Schlager, JJ1
Lucot, JB1
Atchley, DP1
Eckel, LA1

Other Studies

2 other studies available for 8-hydroxy-2-(di-n-propylamino)tetralin and Weight Loss

ArticleYear
The effects of 8-OH-DPAT on neuroinflammation after sarin exposure in mice.
    Toxicology, 2013, Aug-09, Volume: 310

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Apoptosis; Behavior, Animal; Brain; Cholinesterases

2013
Treatment with 8-OH-DPAT attenuates the weight loss associated with activity-based anorexia in female rats.
    Pharmacology, biochemistry, and behavior, 2006, Volume: 83, Issue:4

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anorexia Nervosa; Body Temperature; Eating; Estrus;

2006